latest news releases from the newsroom
Information From Skandia's Board of Directors
STOCKHOLM, Sweden, Sept. 15, 2005 (PRIMEZONE) -- In connection with Old Mutual plc's announcement early this summer to the Board of Directors of Skandia Insurance Company Ltd (publ.) of its interest in making a public offer for all Skandia shares, Old Mutual requested to perform due diligence of Skandia. The Board accepted this request. Prior to the start of this process, a customary confidentiality agreement was reached.
UCB's Anti-Epilectic Keppra Meets Primary End-Point in Monotherapy Trial
BRUSSELS, Belgium, Sept. 15, 2005 (PRIMEZONE) -- UCB today announced that the primary end-point from its pivotal Phase III monotherapy clinical trial had been met. This trial compared Keppra(R) (levetiracetam) to sustained release carbamazepine in newly diagnosed patients, suffering from epilepsy with partial or generalised tonic-clonic seizures. Keppra(R) demonstrated non-inferiority(a) to carbamazepine on seizure freedom1. In addition the trial provided further evidence of Keppra(R)'s favourable tolerability.
Friendly Energy Corporation
Friendly Energy Update
CARSON CITY, Nev., Sept. 14, 2005 (PRIMEZONE) -- Friendly Energy Corporation (Pink Sheets:FDEG) is pleased to announce that it has received commitments from certain institutional investors, subject to formal documentation, to acquire convertible promissory notes and warrants of the Company for gross proceeds of US$1,000,000. The convertible notes can be converted to common shares on the basis of one common share for every US$.05 in value of notes, subject to adjustment. In addition to the notes, the Company has agreed to issue to the investors warrants exercisable into common shares for 3 years at an exercise price of US$.075. Each investor is entitled to half the number of warrants as the number of common shares that would be issued if the whole note is converted at US$.05
Delta Air Lines, Inc.
Delta Air Lines Receives Court Approval For Interim Orders
ATLANTA, Sept. 14, 2005 (PRIMEZONE) -- Delta Air Lines (NYSE: DAL) has announced that Judge Prudence C. Beatty of the U.S. Bankruptcy Court for the Southern District of New York has entered a series of interim orders that will help facilitate Delta's normal operations until the Court rules on the Company's first day motions. A hearing on the first day motions is scheduled to begin at 2 p.m. on Thursday, Sept. 15, 2005, in New York.
Glancy Binkow & Goldberg LLP
Notice of Filing Securities Class Action against Immucor, Inc., Gioacchino De Chirico, Steven C. Ramsey and Edward L. Gallup -- BLUD, BLUDE
LOS ANGELES, Sept. 14, 2005 (PRIMEZONE) -- Notice is hereby given by Glancy Binkow & Goldberg LLP that a Class Action lawsuit was filed in the United States District Court for the Northern District of Georgia on behalf of a class (the "Class") consisting of all persons or entities who purchased or otherwise acquired securities of Immucor, Inc. ("Immucor" or the "Company") (Nasdaq:BLUD) (Nasdaq:BLUDE), between January 7, 2005 and August 29, 2005, inclusive (the "Class Period").
Victory Over Cancer and Chronic Conditions
Victory Over Cancer and Chronic Conditions Director, Floyd Taub, M.D., to Stress How Revolutionary Approach Reduces Fatigue and Other Symptoms of Cancer and Infections Including Lyme Disease and Hepatitis
LYME, Conn., Sept. 14, 2005 (PRIMEZONE) -- Floyd Taub, M.D., Founder and Executive Director of Victory Over Cancer and Chronic Conditions, will appear on Genesis Network, Thursday, September 15, 2005, on Dr. William Deagle's "Midas Report." Dr. Taub will discuss the actions of new products that effect cancer signaling: "DNA Nutraceutical Signaling in Support of Cancer and Chronic Fatigue Syndromes, Anti-inflammatory Modulation and Tissue Healing -- New Nutraceutical Products."